DYN Latest Headlines

Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)

at www.tipranks.com (Thu, 10-Sep 2:40 PM)

Dyne extends slide as J.P. Morgan downgrades on Novartis setback

at seekingalpha.com (Wed, 9-Sep 9:20 AM)

Morgan Stanley Reaffirms Their Buy Rating on Dyne Therapeutics (DYN)

at www.tipranks.com (Wed, 9-Sep 7:55 AM)

Dyne Therapeutics (DYN) Gets a Buy from RBC Capital

at www.tipranks.com (Wed, 9-Sep 7:36 AM)

Dyne Therapeutics Upsizes Public Offering to $375 Million—What the Fundraise Means for the Company’s Pipeline

Market Chameleon (Wed, 22-Jul 7:06 AM)

FDA Priority Review for Dyne’s Z-Rostudirsen Marks Major Step in Duchenne Muscular Dystrophy Treatment

Market Chameleon (Mon, 20-Jul 8:54 AM)

Dyne Therapeutics Secures $400 Million Debt Facility—Strategic Flexibility Boosts Path to Potential Drug Launches

Market Chameleon (Wed, 17-Jun 11:52 AM)